ComCor: Study of Socio-demographic Factors, Behaviors and Practices Associated With Infection With SARS-CoV-2 Responsible for COVID-19

Sponsor
Institut Pasteur (Industry)
Overall Status
Recruiting
CT.gov ID
NCT04607941
Collaborator
National Health Insurance Fund (Other), IPSOS (Other), Santé publique France (Other), Université de Nantes (Other), Assistance Publique - Hôpitaux de Paris (Other), iPLesp (Other)
600,000
2
23.1
300000
12989

Study Details

Study Description

Brief Summary

The objective of the study is to identify socio-demographic factors, behaviors and practices associated with infection with SARS-CoV-2 to help determine where and how patients mostly get infected with SARS-CoV-2.

It is a case-control study including :
  • cases identified by the nationwide system of positive SARS-CoV-2 tests (COVID-19 diagnosis information system, SIDEP) (currently limited to qRT-PCR) and invited to participate by the National Health Insurance (CNAM) which hosts the data from the nationwide test system;

  • controls included via Ipsos, a polling institute with access to personal data from a panel from which they will include controls matched on age (divided into 10-year categories), gender and geographic area (departement);

  • cases will be offered to invite a person they live with to participate in the study offering another case-control analysis inside a household. These participants will be required to report the result of the test as recommended by contact tracing guidelines to determine whether they are cases or controls.

Data will be collected via a self-administered online questionnaire. Some of the participants will be called for a complementary telephone questionnaire to measure reliability of online retrieved data and explore more specific aspects of SARS-CoV-2 transmission.

Condition or Disease Intervention/Treatment Phase
  • Other: Questionnaires
  • Other: Phone interviews

Detailed Description

The objective of the study is to identify socio-demographic factors, behaviors and practices associated with infection with SARS-CoV-2 to help determine where and how patients mostly get infected with SARS-CoV-2.

The study will focus on sociodemographic data (age, gender, location of residence, socio-economic level, etc.), behaviors and practices (adherence to hand-washing, mask-wearing, work habits, meetings, etc.), the places they visit (public transportation, bars, restaurants, sport facilities, etc.).

It is a case-control study including :
  • cases identified by the nationwide system of positive SARS-CoV-2 tests (SIDEP) (currently limited to RT-PCR) and invited to participate by CNAM, which hosts the data from the nationwide test system, through a nationwide email campaign sent once a week; cases will be asked if they can tell where they most probably were infected, leading to a detailed description of the circumstances of the contamination, including whether the suspected contamination took place within the household or not.

  • controls included via Ipsos, a polling institute with access to personal data from a panel from which they will include controls matched on age (divided into 10-year categories up to 68 years old included as expected adherence to an online questionnaire quickly drops beyond that age), gender and geographic area (departement); invitations will be sent every week via email to adapt the profile of recruited controls to the age, gender and geographic profiles of the cases that participated in the previous week;

  • cases will be offered to invite a person they live with to participate in the study offering another case-control analysis inside a household. Cases will be recommended not to invite the person that they suspect was responsible for their contamination, if a intra-household contamination is suspected. They will indicate the email address of that person to allow sending of an invitation via email. These participants will be required to report the result of the test as recommended by contact tracing guidelines to determine whether they are cases or controls.

Analysis will also include descriptive analysis:
  • Estimation of the proportion of cases infected within the household or outside

  • Among the cases with a extra-household contamination suspicion, proportion of cases for whom infection circumstances are known and description of these circumstances

  • Proportion of cases for whom no specific circumstance of contamination could be evidenced.

Questionnaires will focus on the 10 days preceding :
  • symptom onset (symptomatic cases)

  • day of testing (asymptomatic cases)

  • day of symptom onset of the first case within a household (people from the same household as cases) or testing of the first case if they are asymptomatic

  • questionnaire completion (Ipsos-recruited controls)

Participants will be offered at the end of the online self-administered questionnaire to indicate a phone number. Among those agreeing to do so, a random sample of case-control pairs and cases of particular interest (eg with specific contamination circumstances) will be called within two weeks following the online questionnaire for a more detailed telephone questionnaire to measure reliability of online retrieved data and explore more specific aspects of SARS-CoV-2 transmission.

Study Design

Study Type:
Observational
Anticipated Enrollment :
600000 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Study of Socio-demographic Factors, Behaviors and Practices Associated With Infection With SARS-CoV-2
Actual Study Start Date :
Oct 27, 2020
Anticipated Primary Completion Date :
Sep 30, 2022
Anticipated Study Completion Date :
Sep 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Cases

Subjects diagnosed as positive for SARS-CoV-2 infection

Other: Questionnaires
Self-administered questionnaires

Other: Phone interviews
A small amount of subjects will be selected at random for phone interviews.

Close Subjects

Subjects living within the same household as cases: close cases if tested positive for SARS-CoV-2 following contact tracing recommendations close controls if tested negative for SARS-CoV-2 following contact tracing recommendations

Other: Questionnaires
Self-administered questionnaires

Other: Phone interviews
A small amount of subjects will be selected at random for phone interviews.

Control Subjects

Controls selected within the population to allow for an age, gender and location of residence-matched analysis with cases

Other: Questionnaires
Self-administered questionnaires

Other: Phone interviews
A small amount of subjects will be selected at random for phone interviews.

Outcome Measures

Primary Outcome Measures

  1. Odds-ratios of SARS-CoV-2 infection on socio-demographic factors, behaviors and practices and visited places reported by the participants in the online questionnaire [1 year]

    Odds-ratios of SARS-CoV-2 infection on socio-demographic factors, behaviors and practices and visited places through case-control analyses.

Secondary Outcome Measures

  1. Proportion of cases infected in family environment by SARS-CoV-2 reported by participants in the phone interview [1 year]

    Proportion of cases reporting likely contamination circumstances in the family environment

  2. Proportion of cases infected in family environment by SARS-CoV-2 reported by participants in the online questionnaire [1 year]

    Proportion of cases reporting likely contamination circumstances in the family environment

  3. Proportion of cases infected in professional environment by SARS-CoV-2 reported by participants in the phone interview [1 year]

    Proportion of cases reporting likely contamination circumstances in the professional environment

  4. Proportion of cases infected in professional environment by SARS-CoV-2 reported by participants in the online questionnaire [1 year]

    Proportion of cases reporting likely contamination circumstances in the professional environment

  5. Level of adherence to mask-wearing reported in the phone interview [1 year]

    Proportion of participants reporting adherence to mask-wearing

  6. Level of adherence to mask-wearing reported in the online questionnaire [1 year]

    Proportion of participants reporting adherence to mask-wearing

  7. Level of adherence to hand-washing in the phone interview [1 year]

    Proportion of participants reporting adherence to hand-washing

  8. Level of adherence to hand-washing in the online questionnaire [1 year]

    Proportion of participants reporting adherence to hand-washing

  9. Odds-ratios of SARS-CoV-2 infection on socio-demographic factors, behaviors and practices and visited places reported by the participants in the phone interview [1 year]

    Odds-ratios of SARS-CoV-2 infection on socio-demographic factors, behaviors and practices and visited places through case-control analyses.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
All participants:
  • Aged 18 years or more

  • Agreeing to participate in the study

Index cases:
  • Cases identified by the National Health Insurance (CNAM) in the nationwide database SIDEP (COVID-19 diagnosis information system)

  • Positive SARS-CoV-2 RT-PCR on nasopharyngeal or throat swab (or another sample which state of the art considers that it indicates an active infection if positive)

"Distant" controls:

  • Selected by Ipsos among Ipsos' panel on age, gender and location of residence criteria (to allow for matched case-control analysis)

  • Health Care Workers

Close subjects:
  • People who live in the same household as a case and who have been invited to participate by that case

  • People who have had a RT-PCR test on nasopharyngeal or throat swab (or another sample which state of the art considers it indicates an active infection if positive) following diagnosis of the index case (following contact tracing recommendations), classified as:

  • close cases if test is positive

  • close controls if test is negative

Exclusion Criteria:
For all participants:
  • People under judicial protection measures ("sauvegarde de justice", "curatelle", "curatelle renforcée", "tutelle", ie various forms of curatorship under French law)
For related cases, related controls and "distant" controls:
  • People with a history of SARS-CoV-2 infection confirmed by RT-PCR or positive testing of anti-SARS-CoV-2 antibodies with serology (for related cases: before the current episode)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Caisse Nationale d'Assurance Maladie Paris France
2 IPSOS Paris France

Sponsors and Collaborators

  • Institut Pasteur
  • National Health Insurance Fund
  • IPSOS
  • Santé publique France
  • Université de Nantes
  • Assistance Publique - Hôpitaux de Paris
  • iPLesp

Investigators

  • Principal Investigator: Arnaud Fontanet, Pr, Institut Pasteur

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Institut Pasteur
ClinicalTrials.gov Identifier:
NCT04607941
Other Study ID Numbers:
  • 2020-047
  • 2020-A02560-39
First Posted:
Oct 29, 2020
Last Update Posted:
Apr 21, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Institut Pasteur
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 21, 2022